Bank of New York Mellon’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.99M Buy
254,380
+24,389
+11% +$1.03M ﹤0.01% 2147
2026
Q1
$12.7M Sell
229,991
-2,192
-0.9% -$104K ﹤0.01% 1799
2025
Q4
$8.67M Sell
232,183
-34,920
-13% -$1.42M ﹤0.01% 2006
2025
Q3
$10.8M Sell
267,103
-1,774
-0.7% -$58.6K ﹤0.01% 1885
2025
Q2
$6.87M Buy
268,877
+906
+0.3% +$19.8K ﹤0.01% 2094
2025
Q1
$5.72M Sell
267,971
-4,661
-2% -$104K ﹤0.01% 2155
2024
Q4
$5.73M Buy
272,632
+7,747
+3% +$179K ﹤0.01% 2219
2024
Q3
$5.97M Buy
264,885
+18,067
+7% +$349K ﹤0.01% 2206
2024
Q2
$4.14M Sell
246,818
-435
-0.2% -$6.99K ﹤0.01% 2427
2024
Q1
$3.2M Buy
247,253
+3,807
+2% +$45.6K ﹤0.01% 2527
2023
Q4
$2.82M Sell
243,446
-219,978
-47% -$2.48M ﹤0.01% 2649
2023
Q3
$5.92M Sell
463,424
-14,306
-3% -$203K ﹤0.01% 2225
2023
Q2
$6.54M Sell
477,730
-4,811
-1% -$68.9K ﹤0.01% 2174
2023
Q1
$7.39M Sell
482,541
-11,661
-2% -$178K ﹤0.01% 2090
2022
Q4
$6.63M Buy
494,202
+74,317
+18% +$997K ﹤0.01% 2170
2022
Q3
$5.58M Sell
419,885
-20,444
-5% -$353K ﹤0.01% 2239
2022
Q2
$8.42M Buy
440,329
+4,464
+1% +$84.5K ﹤0.01% 2043
2022
Q1
$8.7M Sell
435,865
-6,989
-2% -$141K ﹤0.01% 2145
2021
Q4
$9.04M Sell
442,854
-24,122
-5% -$515K ﹤0.01% 2160
2021
Q3
$10.1M Buy
466,976
+29,330
+7% +$706K ﹤0.01% 2113
2021
Q2
$12.6M Sell
437,646
-11,701
-3% -$316K ﹤0.01% 1998
2021
Q1
$11M Buy
449,347
+28,745
+7% +$649K ﹤0.01% 2035
2020
Q4
$8.17M Buy
420,602
+67,024
+19% +$1.23M ﹤0.01% 2103
2020
Q3
$6.15M Buy
353,578
+61,793
+21% +$1.32M ﹤0.01% 2110
2020
Q2
$7.67M Sell
291,785
-5,691
-2% -$141K ﹤0.01% 1982
2020
Q1
$7.19M Buy
297,476
+7,487
+3% +$183K ﹤0.01% 1874
2019
Q4
$7.2M Sell
289,989
-18,445
-6% -$428K ﹤0.01% 2153
2019
Q3
$6.58M Sell
308,434
-2,971
-1% -$81.4K ﹤0.01% 2151
2019
Q2
$9.89M Sell
311,405
-12,745
-4% -$400K ﹤0.01% 1972
2019
Q1
$10.7M Sell
324,150
-34,231
-10% -$1.07M ﹤0.01% 1936
2018
Q4
$11.5M Sell
358,381
-2,923
-0.8% -$110K ﹤0.01% 1816
2018
Q3
$15.5M Buy
361,304
+11,730
+3% +$554K ﹤0.01% 1797
2018
Q2
$16.1M Buy
349,574
+10,895
+3% +$482K ﹤0.01% 1732
2018
Q1
$13.4M Buy
338,679
+14,314
+4% +$530K ﹤0.01% 1829
2017
Q4
$10.9M Sell
324,365
-21,303
-6% -$756K ﹤0.01% 1952
2017
Q3
$12.8M Sell
345,668
-7,430
-2% -$279K ﹤0.01% 1857
2017
Q2
$13.1M Buy
353,098
+5,441
+2% +$178K ﹤0.01% 1825
2017
Q1
$9.77M Buy
347,657
+40,735
+13% +$1.15M ﹤0.01% 1982
2016
Q4
$8.99M Buy
306,922
+60,487
+25% +$1.65M ﹤0.01% 2012
2016
Q3
$6.7M Sell
246,435
-26,708
-10% -$604K ﹤0.01% 2090
2016
Q2
$5.1M Sell
273,143
-10,082
-4% -$210K ﹤0.01% 2202
2016
Q1
$7.66M Buy
283,225
+21,848
+8% +$626K ﹤0.01% 1972
2015
Q4
$7.88M Buy
261,377
+151,031
+137% +$4.85M ﹤0.01% 1972
2015
Q3
$3.49M Sell
110,346
-5,369
-5% -$196K ﹤0.01% 2426
2015
Q2
$4.51M Buy
115,715
+15,735
+16% +$543K ﹤0.01% 2415
2015
Q1
$3.54M Sell
99,980
-18,282
-15% -$589K ﹤0.01% 2505
2014
Q4
$3.73M Buy
118,262
+59,233
+100% +$1.64M ﹤0.01% 2470
2014
Q3
$1.32M Buy
59,029
+13,258
+29% +$266K ﹤0.01% 3131
2014
Q2
$1M Buy
+45,771
New +$870K ﹤0.01% 3308

Other funds holding PAHC

Bank of New York Mellon's PAHC Position: Q2 2026 in Review

Bank of New York Mellon increased its Phibro Animal Health (PAHC) stake by 11% in Q2 2026, buying an estimated $1.03M and bringing the position to 254,380 shares worth $7.99M. The position accounts for ﹤0.01% of the portfolio, ranked #2147.

Bank of New York Mellon first reported a position in PAHC in Q2 2014 and has held it in 49 quarters since. The position peaked at $16.1M in Q2 2018. 117 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Bank of New York Mellon held 254,380 shares of Phibro Animal Health worth $7.99M as of Q2 2026.
  • Bank of New York Mellon bought 24,389 Phibro Animal Health shares in Q2 2026, an estimated $1.03M.
  • Phibro Animal Health made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2147 holding.
  • Bank of New York Mellon first reported a position in Phibro Animal Health in Q2 2014 and has held it in 49 quarters since.
  • Bank of New York Mellon's Phibro Animal Health position peaked at $16.1M in Q2 2018.
  • 117 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.